APO Research
Talk to an analyst

APO RESEARCH · REPORT

Clavulanic Acid (API)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Clavulanic Acid (API) Industry Growth and Trends Forecast to 2032

21 December 202599 pages

Choose your research edition.

Industry ResearchClavulanic Acid (API) Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Clavulanic Acid (API) Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Clavulanic Acid (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clavulanic Acid (API) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Clavulanic Acid (API) Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

Global Clavulanic Acid key players include GSK, Novartis, Sinopharm Sandwich Dayao Ye Ltd., Shandong New Time Pharmaceutical, Teva Pharmaceutical Industries Limited, United Laboratories, CSPC Pharmaceutical, Sun Pharmaceutical Industries Ltd., NCPC, etc.

Report Scope

This report provides a structured, data-driven view of the global Clavulanic Acid (API) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

Read the full market overview

The Clavulanic Acid (API) market size, estimates, and forecasts are presented in terms of sales volume (kt) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Clavulanic Acid (API) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant toClavulanic Acid (API).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Clavulanic Acid (API) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Clavulanic Acid (API) Market by Company

GSK

Novartis

Sinopharm Sandwich Dayao Ye Ltd.

Shandong New Time Pharmaceutical

Teva Pharmaceutical Industries Limited

United Laboratories

CSPC Pharmaceutical

Sun Pharmaceutical Industries Ltd.

NCPC

Clavulanic Acid (API) Segment by Type

1:1

2:1

4:1

Others

Clavulanic Acid (API) Segment by Application

Combined with Amoxicillin

Combined with Ticarcillin

Clavulanic Acid (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clavulanic Acid (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clavulanic Acid (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clavulanic Acid (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Clavulanic Acid (API) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Clavulanic Acid (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1:1 Table 2. Major Company of 2:1 Table 3. Major Company of 4:1 Table 4. Major Company of Others Table 5. Global Clavulanic Acid (API) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Clavulanic Acid (API) Sales by Type (2021-2026) & (kt) Table 7. Global Clavulanic Acid (API) Sales Market Share in Volume by Type (2021-2026) Table 8. Global Clavulanic Acid (API) Sales by Type (2021-2026) & (US$ Million) Table 9. Global Clavulanic Acid (API) Sales Market Share in Value by Type (2021-2026) Table 10. Global Clavulanic Acid (API) Price by Type (2021-2026) & (USD/t) Table 11. Global Clavulanic Acid (API) Sales by Type (2027-2032) & (kt) Table 12. Global Clavulanic Acid (API) Sales Market Share in Volume by Type (2027-2032) Table 13. Global Clavulanic Acid (API) Sales by Type (2027-2032) & (US$ Million) Table 14. Global Clavulanic Acid (API) Sales Market Share in Value by Type (2027-2032) Table 15. Global Clavulanic Acid (API) Price by Type (2027-2032) & (USD/t) Table 16. North America Clavulanic Acid (API) Sales by Type (2021-2026) & (kt) Table 17. North America Clavulanic Acid (API) Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Clavulanic Acid (API) Sales by Type (2021-2026) & (kt) Table 19. Europe Clavulanic Acid (API) Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Clavulanic Acid (API) Sales by Type (2021-2026) & (kt) Table 21. Asia-Pacific Clavulanic Acid (API) Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Clavulanic Acid (API) Sales by Type (2021-2026) & (kt) Table 23. Latin America Clavulanic Acid (API) Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Clavulanic Acid (API) Sales by Type (2021-2026) & (kt) Table 25. Middle East and Africa Clavulanic Acid (API) Sales by Type (2021-2026) & (US$ Million) Table 26. Clavulanic Acid (API) Industry Trends Table 27. Clavulanic Acid (API) Industry Drivers Table 28. Clavulanic Acid (API) Industry Opportunities and Challenges Table 29. Clavulanic Acid (API) Industry Restraints Table 30. Global Clavulanic Acid (API) Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Clavulanic Acid (API) Revenue Market Share by Company (2021-2026) Table 32. Global Clavulanic Acid (API) Sales by Company (2021-2026) & (kt) Table 33. Global Clavulanic Acid (API) Sales Share by Company (2021-2026) Table 34. Global Clavulanic Acid (API) Market Price by Company (2021-2026) & (USD/t) Table 35. Global Clavulanic Acid (API) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Clavulanic Acid (API) Major Company Production Sites and Headquarters Table 37. Global Clavulanic Acid (API) Company, Product Type & Application Table 38. Global Clavulanic Acid (API) Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Clavulanic Acid (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Clavulanic Acid (API) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Clavulanic Acid (API) Sales by Region (2021-2026) & (kt) Table 43. Global Clavulanic Acid (API) Sales Market Share in Volume by Region (2021-2026) Table 44. Global Clavulanic Acid (API) Sales by Region (2021-2026) & (US$ Million) Table 45. Global Clavulanic Acid (API) Sales Market Share in Value by Region (2021-2026) Table 46. Global Clavulanic Acid (API) Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 47. Global Clavulanic Acid (API) Sales by Region (2027-2032) & (kt) Table 48. Global Clavulanic Acid (API) Sales Market Share in Volume by Region (2027-2032) Table 49. Global Clavulanic Acid (API) Sales by Region (2027-2032) & (US$ Million) Table 50. Global Clavulanic Acid (API) Sales Market Share in Value by Region (2027-2032) Table 51. Global Clavulanic Acid (API) Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 52. Global Clavulanic Acid (API) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Clavulanic Acid (API) Sales by Application (2021-2026) & (kt) Table 54. Global Clavulanic Acid (API) Sales Market Share in Volume by Application (2021-2026) Table 55. Global Clavulanic Acid (API) Sales by Application (2021-2026) & (US$ Million) Table 56. Global Clavulanic Acid (API) Sales Market Share in Value by Application (2021-2026) Table 57. Global Clavulanic Acid (API) Price by Application (2021-2026) & (USD/t) Table 58. Global Clavulanic Acid (API) Sales by Application (2027-2032) & (kt) Table 59. Global Clavulanic Acid (API) Sales Market Share in Volume by Application (2027-2032) Table 60. Global Clavulanic Acid (API) Sales by Application (2027-2032) & (US$ Million) Table 61. Global Clavulanic Acid (API) Sales Market Share in Value by Application (2027-2032) Table 62. Global Clavulanic Acid (API) Price by Application (2027-2032) & (USD/t) Table 63. North America Clavulanic Acid (API) Sales by Application (2021-2026) & (kt) Table 64. North America Clavulanic Acid (API) Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Clavulanic Acid (API) Sales by Application (2021-2026) & (kt) Table 66. Europe Clavulanic Acid (API) Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Clavulanic Acid (API) Sales by Application (2021-2026) & (kt) Table 68. Asia-Pacific Clavulanic Acid (API) Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Clavulanic Acid (API) Sales by Application (2021-2026) & (kt) Table 70. Latin America Clavulanic Acid (API) Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Clavulanic Acid (API) Sales by Application (2021-2026) & (kt) Table 72. Middle East and Africa Clavulanic Acid (API) Sales by Application (2021-2026) & (US$ Million) Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Clavulanic Acid (API) Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. GSK Clavulanic Acid (API) Product Portfolio Table 77. GSK Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Clavulanic Acid (API) Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Novartis Clavulanic Acid (API) Product Portfolio Table 82. Novartis Recent Development Table 83. Sinopharm Sandwich Dayao Ye Ltd. Company Information Table 84. Sinopharm Sandwich Dayao Ye Ltd. Business Overview Table 85. Sinopharm Sandwich Dayao Ye Ltd. Clavulanic Acid (API) Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. Sinopharm Sandwich Dayao Ye Ltd. Clavulanic Acid (API) Product Portfolio Table 87. Sinopharm Sandwich Dayao Ye Ltd. Recent Development Table 88. Shandong New Time Pharmaceutical Company Information Table 89. Shandong New Time Pharmaceutical Business Overview Table 90. Shandong New Time Pharmaceutical Clavulanic Acid (API) Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Shandong New Time Pharmaceutical Clavulanic Acid (API) Product Portfolio Table 92. Shandong New Time Pharmaceutical Recent Development Table 93. Teva Pharmaceutical Industries Limited Company Information Table 94. Teva Pharmaceutical Industries Limited Business Overview Table 95. Teva Pharmaceutical Industries Limited Clavulanic Acid (API) Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Teva Pharmaceutical Industries Limited Clavulanic Acid (API) Product Portfolio Table 97. Teva Pharmaceutical Industries Limited Recent Development Table 98. United Laboratories Company Information Table 99. United Laboratories Business Overview Table 100. United Laboratories Clavulanic Acid (API) Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. United Laboratories Clavulanic Acid (API) Product Portfolio Table 102. United Laboratories Recent Development Table 103. CSPC Pharmaceutical Company Information Table 104. CSPC Pharmaceutical Business Overview Table 105. CSPC Pharmaceutical Clavulanic Acid (API) Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. CSPC Pharmaceutical Clavulanic Acid (API) Product Portfolio Table 107. CSPC Pharmaceutical Recent Development Table 108. Sun Pharmaceutical Industries Ltd. Company Information Table 109. Sun Pharmaceutical Industries Ltd. Business Overview Table 110. Sun Pharmaceutical Industries Ltd. Clavulanic Acid (API) Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. Sun Pharmaceutical Industries Ltd. Clavulanic Acid (API) Product Portfolio Table 112. Sun Pharmaceutical Industries Ltd. Recent Development Table 113. NCPC Company Information Table 114. NCPC Business Overview Table 115. NCPC Clavulanic Acid (API) Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 116. NCPC Clavulanic Acid (API) Product Portfolio Table 117. NCPC Recent Development Table 118. North America Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 119. North America Clavulanic Acid (API) Sales by Country (2021-2026) & (kt) Table 120. North America Clavulanic Acid (API) Sales Market Share by Country (2021-2026) Table 121. North America Clavulanic Acid (API) Sales Forecast by Country (2027-2032) & (kt) Table 122. North America Clavulanic Acid (API) Sales Market Share Forecast by Country (2027-2032) Table 123. North America Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Clavulanic Acid (API) Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Clavulanic Acid (API) Market Share by Country (2021-2026) Table 126. North America Clavulanic Acid (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Clavulanic Acid (API) Market Share Forecast by Country (2027-2032) Table 128. Europe Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 129. Europe Clavulanic Acid (API) Sales by Country (2021-2026) & (kt) Table 130. Europe Clavulanic Acid (API) Sales Market Share by Country (2021-2026) Table 131. Europe Clavulanic Acid (API) Sales Forecast by Country (2027-2032) & (kt) Table 132. Europe Clavulanic Acid (API) Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Clavulanic Acid (API) Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Clavulanic Acid (API) Market Share by Country (2021-2026) Table 136. Europe Clavulanic Acid (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Clavulanic Acid (API) Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Clavulanic Acid (API) Sales by Country (2021-2026) & (kt) Table 140. Asia-Pacific Clavulanic Acid (API) Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Clavulanic Acid (API) Sales Forecast by Country (2027-2032) & (kt) Table 142. Asia-Pacific Clavulanic Acid (API) Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Clavulanic Acid (API) Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Clavulanic Acid (API) Market Share by Country (2021-2026) Table 146. Asia-Pacific Clavulanic Acid (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Clavulanic Acid (API) Market Share Forecast by Country (2027-2032) Table 148. Latin America Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 149. Latin America Clavulanic Acid (API) Sales by Country (2021-2026) & (kt) Table 150. Latin America Clavulanic Acid (API) Sales Market Share by Country (2021-2026) Table 151. Latin America Clavulanic Acid (API) Sales Forecast by Country (2027-2032) & (kt) Table 152. Latin America Clavulanic Acid (API) Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Clavulanic Acid (API) Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Clavulanic Acid (API) Market Share by Country (2021-2026) Table 156. Latin America Clavulanic Acid (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Clavulanic Acid (API) Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Clavulanic Acid (API) Sales by Country (2021-2026) & (kt) Table 160. Middle East and Africa Clavulanic Acid (API) Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Clavulanic Acid (API) Sales Forecast by Country (2027-2032) & (kt) Table 162. Middle East and Africa Clavulanic Acid (API) Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Clavulanic Acid (API) Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Clavulanic Acid (API) Market Share by Country (2021-2026) Table 166. Middle East and Africa Clavulanic Acid (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Clavulanic Acid (API) Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Clavulanic Acid (API) Distributors List Table 171. Clavulanic Acid (API) Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Clavulanic Acid (API) Image Figure 2. Global Clavulanic Acid (API) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clavulanic Acid (API) Market Size (2021-2032) & (US$ Million) Figure 4. Global Clavulanic Acid (API) Sales (2021-2032) & (kt) Figure 5. 1:1 Image Figure 6. Global 1:1 Sales YoY Growth (2021-2032) & (kt) Figure 7. 2:1 Image Figure 8. Global 2:1 Sales YoY Growth (2021-2032) & (kt) Figure 9. 4:1 Image Figure 10. Global 4:1 Sales YoY Growth (2021-2032) & (kt) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (kt) Figure 13. Global Clavulanic Acid (API) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Clavulanic Acid (API) Market Share by Type 2025 VS 2032 Figure 15. North America Clavulanic Acid (API) Sales Market Share in Volume by Type in 2025 Figure 16. North America Clavulanic Acid (API) Sales Market Share in Value by Type in 2025 Figure 17. Europe Clavulanic Acid (API) Sales Market Share in Volume by Type in 2025 Figure 18. Europe Clavulanic Acid (API) Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Clavulanic Acid (API) Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Clavulanic Acid (API) Sales Market Share in Value by Type in 2025 Figure 21. Latin America Clavulanic Acid (API) Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Clavulanic Acid (API) Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Clavulanic Acid (API) Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Clavulanic Acid (API) Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Clavulanic Acid (API) Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Combined with Amoxicillin Image Figure 28. Global Combined with Amoxicillin Sales YoY Growth (2021-2032) & (kt) Figure 29. Combined with Ticarcillin Image Figure 30. Global Combined with Ticarcillin Sales YoY Growth (2021-2032) & (kt) Figure 31. Global Clavulanic Acid (API) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Clavulanic Acid (API) Market Share by Application 2025 VS 2032 Figure 33. North America Clavulanic Acid (API) Sales Market Share in Volume by Application in 2025 Figure 34. North America Clavulanic Acid (API) Sales Market Share in Value by Application in 2025 Figure 35. Europe Clavulanic Acid (API) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Clavulanic Acid (API) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Clavulanic Acid (API) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Clavulanic Acid (API) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Clavulanic Acid (API) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Clavulanic Acid (API) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Clavulanic Acid (API) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Clavulanic Acid (API) Sales Market Share in Value by Application in 2025 Figure 43. North America Clavulanic Acid (API) Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 44. North America Clavulanic Acid (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Clavulanic Acid (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Clavulanic Acid (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Clavulanic Acid (API) Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 48. Europe Clavulanic Acid (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Clavulanic Acid (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Clavulanic Acid (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Clavulanic Acid (API) Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 52. Asia-Pacific Clavulanic Acid (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Clavulanic Acid (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Clavulanic Acid (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Clavulanic Acid (API) Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 56. Latin America Clavulanic Acid (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Clavulanic Acid (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Clavulanic Acid (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Clavulanic Acid (API) Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 60. Middle East and Africa Clavulanic Acid (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Clavulanic Acid (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Clavulanic Acid (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Clavulanic Acid (API) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Clavulanic Acid (API) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1:1
  • 2:1
  • 4:1
  • Others
Applications
  • Combined with Amoxicillin
  • Combined with Ticarcillin
Companies covered
  • GSK
  • Novartis
  • Sinopharm Sandwich Dayao Ye Ltd.
  • Shandong New Time Pharmaceutical
  • Teva Pharmaceutical Industries Limited
  • United Laboratories
  • CSPC Pharmaceutical
  • Sun Pharmaceutical Industries Ltd.
  • NCPC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Clavulanic Acid (API) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Clavulanic Acid (API) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Clavulanic Acid (API) Market by Type
  6. 1.3.1 1:1
  7. 1.3.2 2:1
  8. 1.3.3 4:1
  9. 1.3.4 Others
  10. 1.4 Global Clavulanic Acid (API) Market Size by Type
  11. 1.4.1 Global Clavulanic Acid (API) Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Clavulanic Acid (API) Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Clavulanic Acid (API) Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Clavulanic Acid (API) Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Clavulanic Acid (API) Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Clavulanic Acid (API) Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Clavulanic Acid (API) Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Clavulanic Acid (API) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Clavulanic Acid (API) Industry Trends
  2. 2.2 Clavulanic Acid (API) Industry Drivers
  3. 2.3 Clavulanic Acid (API) Industry Opportunities and Challenges
  4. 2.4 Clavulanic Acid (API) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Clavulanic Acid (API) Revenue (2021-2026)
  2. 3.2 Global Top Players by Clavulanic Acid (API) Sales (2021-2026)
  3. 3.3 Global Top Players by Clavulanic Acid (API) Price (2021-2026)
  4. 3.4 Global Clavulanic Acid (API) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Clavulanic Acid (API) Major Company Production Sites & Headquarters
  6. 3.6 Global Clavulanic Acid (API) Company, Product Type & Application
  7. 3.7 Global Clavulanic Acid (API) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Clavulanic Acid (API) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Clavulanic Acid (API) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Clavulanic Acid (API) Tier 1, Tier 2, and Tier 3
4 Clavulanic Acid (API) Regional Status and Outlook
  1. 4.1 Global Clavulanic Acid (API) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Clavulanic Acid (API) Historic Market Size by Region
  3. 4.2.1 Global Clavulanic Acid (API) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Clavulanic Acid (API) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Clavulanic Acid (API) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Clavulanic Acid (API) Forecasted Market Size by Region
  7. 4.3.1 Global Clavulanic Acid (API) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Clavulanic Acid (API) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Clavulanic Acid (API) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Clavulanic Acid (API) by Application
  1. 5.1 Clavulanic Acid (API) Market by Application
  2. 5.1.1 Combined with Amoxicillin
  3. 5.1.2 Combined with Ticarcillin
  4. 5.2 Global Clavulanic Acid (API) Market Size by Application
  5. 5.2.1 Global Clavulanic Acid (API) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Clavulanic Acid (API) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Clavulanic Acid (API) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Clavulanic Acid (API) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Clavulanic Acid (API) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Clavulanic Acid (API) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Clavulanic Acid (API) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Clavulanic Acid (API) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Clavulanic Acid (API) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Clavulanic Acid (API) Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Clavulanic Acid (API) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Clavulanic Acid (API) Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Sinopharm Sandwich Dayao Ye Ltd.
  14. 6.3.1 Sinopharm Sandwich Dayao Ye Ltd. Company Information
  15. 6.3.2 Sinopharm Sandwich Dayao Ye Ltd. Business Overview
  16. 6.3.3 Sinopharm Sandwich Dayao Ye Ltd. Clavulanic Acid (API) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sinopharm Sandwich Dayao Ye Ltd. Clavulanic Acid (API) Product Portfolio
  18. 6.3.5 Sinopharm Sandwich Dayao Ye Ltd. Recent Developments
  19. 6.4 Shandong New Time Pharmaceutical
  20. 6.4.1 Shandong New Time Pharmaceutical Company Information
  21. 6.4.2 Shandong New Time Pharmaceutical Business Overview
  22. 6.4.3 Shandong New Time Pharmaceutical Clavulanic Acid (API) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shandong New Time Pharmaceutical Clavulanic Acid (API) Product Portfolio
  24. 6.4.5 Shandong New Time Pharmaceutical Recent Developments
  25. 6.5 Teva Pharmaceutical Industries Limited
  26. 6.5.1 Teva Pharmaceutical Industries Limited Company Information
  27. 6.5.2 Teva Pharmaceutical Industries Limited Business Overview
  28. 6.5.3 Teva Pharmaceutical Industries Limited Clavulanic Acid (API) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Pharmaceutical Industries Limited Clavulanic Acid (API) Product Portfolio
  30. 6.5.5 Teva Pharmaceutical Industries Limited Recent Developments
  31. 6.6 United Laboratories
  32. 6.6.1 United Laboratories Company Information
  33. 6.6.2 United Laboratories Business Overview
  34. 6.6.3 United Laboratories Clavulanic Acid (API) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 United Laboratories Clavulanic Acid (API) Product Portfolio
  36. 6.6.5 United Laboratories Recent Developments
  37. 6.7 CSPC Pharmaceutical
  38. 6.7.1 CSPC Pharmaceutical Company Information
  39. 6.7.2 CSPC Pharmaceutical Business Overview
  40. 6.7.3 CSPC Pharmaceutical Clavulanic Acid (API) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CSPC Pharmaceutical Clavulanic Acid (API) Product Portfolio
  42. 6.7.5 CSPC Pharmaceutical Recent Developments
  43. 6.8 Sun Pharmaceutical Industries Ltd.
  44. 6.8.1 Sun Pharmaceutical Industries Ltd. Company Information
  45. 6.8.2 Sun Pharmaceutical Industries Ltd. Business Overview
  46. 6.8.3 Sun Pharmaceutical Industries Ltd. Clavulanic Acid (API) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Industries Ltd. Clavulanic Acid (API) Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  49. 6.9 NCPC
  50. 6.9.1 NCPC Company Information
  51. 6.9.2 NCPC Business Overview
  52. 6.9.3 NCPC Clavulanic Acid (API) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 NCPC Clavulanic Acid (API) Product Portfolio
  54. 6.9.5 NCPC Recent Developments
7 North America by Country
  1. 7.1 North America Clavulanic Acid (API) Sales by Country
  2. 7.1.1 North America Clavulanic Acid (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Clavulanic Acid (API) Sales by Country (2021-2026)
  4. 7.1.3 North America Clavulanic Acid (API) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Clavulanic Acid (API) Market Size by Country
  6. 7.2.1 North America Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Clavulanic Acid (API) Market Size by Country (2021-2026)
  8. 7.2.3 North America Clavulanic Acid (API) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Clavulanic Acid (API) Sales by Country
  2. 8.1.1 Europe Clavulanic Acid (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Clavulanic Acid (API) Sales by Country (2021-2026)
  4. 8.1.3 Europe Clavulanic Acid (API) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Clavulanic Acid (API) Market Size by Country
  6. 8.2.1 Europe Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Clavulanic Acid (API) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Clavulanic Acid (API) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Clavulanic Acid (API) Sales by Country
  2. 9.1.1 Asia-Pacific Clavulanic Acid (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Clavulanic Acid (API) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Clavulanic Acid (API) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Clavulanic Acid (API) Market Size by Country
  6. 9.2.1 Asia-Pacific Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Clavulanic Acid (API) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Clavulanic Acid (API) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Clavulanic Acid (API) Sales by Country
  2. 10.1.1 South America Clavulanic Acid (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Clavulanic Acid (API) Sales by Country (2021-2026)
  4. 10.1.3 South America Clavulanic Acid (API) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Clavulanic Acid (API) Market Size by Country
  6. 10.2.1 South America Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Clavulanic Acid (API) Market Size by Country (2021-2026)
  8. 10.2.3 South America Clavulanic Acid (API) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Clavulanic Acid (API) Sales by Country
  2. 11.1.1 Middle East and Africa Clavulanic Acid (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Clavulanic Acid (API) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Clavulanic Acid (API) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Clavulanic Acid (API) Market Size by Country
  6. 11.2.1 Middle East and Africa Clavulanic Acid (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Clavulanic Acid (API) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Clavulanic Acid (API) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Clavulanic Acid (API) Value Chain Analysis
  2. 12.1.1 Clavulanic Acid (API) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Clavulanic Acid (API) Production Mode & Process
  7. 12.2 Clavulanic Acid (API) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Clavulanic Acid (API) Distributors
  10. 12.2.3 Clavulanic Acid (API) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst